Citations

Showing 10 of 108152 citations.

Differences in Optical Coherence Tomography of the Macula in Advanced Glaucoma and After a Retinal Artery Occlusion
Shetty, Rajesh , Boilling, James P, Stewart, Michael W., Shetty, Rajesh K, Heckman, Michael G.

Mayo Clinic

Ophthalmic Surgery, Lasers and Imaging Retina | October 7, 2019 | Volume: 38 | Issue: 5 | Pages: 392-398

10.3928/15428877-20070901-06 | PMID 17955844 Get It

Background and Objective: Optical coherence tomography (OCT) was used to evaluate the macular thickness in eyes with advanced glaucoma compared with eyes following a retinal artery occlusion. Patients and Methods: Ten patients with a retinal artery occlusion and 10 patients with severe glaucoma were evaluated with OCT using the macular thickness map protocol. Results: The median thinnest macular sector was 183 microns (range: 152 to 223 microns) in patients with glaucoma versus 143 microns (range: 98 to 177 microns) in patients with arterial occlusion ( P = .001). Median macular volume was 5.9 mm 3 (range: 5.1 to 6.7 mm 3 ) in patients with glaucoma versus 5.1 mm 3 (range: 3.6 to 6.1 mm 3 ) in patients with arterial occlusion ( P = .015). Conclusions OCT demonstrates that patients with a retinal artery occlusion have significantly reduced macular thickness compared with those with severe glaucoma. [Ophthalmic Surg Lasers Imaging 2007;38:392–398.]
Faculty Opinions recommendation of CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies.
Ansell, Stephen M.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | October 7, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.736662305.793565659 Get It

Long-Term Outcomes of Stereotactic Radiosurgery for Vestibular Schwannoma Associated with Neurofibromatosis Type 2 in Comparison to Sporadic Schwannoma
Shinya, Yuki , Hasegawa, Hirotaka , Shin, Masahiro , Sugiyama, Takehiro , Kawashima, Mariko , Takahashi, Wataru , Kashio, Akinori , Saito, Nobuhito , Iwasaki, Shinichi , Nakatomi, Hirofumi , Shinya, Yuki

Mayo Clinic

Cancers | October 7, 2019 | Volume: 11 | Issue: 10 | Pages: 1498

10.3390/cancers11101498 | PMID 31591325 Get It

The efficacy of radiosurgery for neurofibromatosis type 2 (NF2)-associated vestibular schwannoma (VS) remains debatable. We retrospectively analyzed radiosurgical outcomes for NF2-associated VS compared to sporadic VS using our database of 422 consecutive VS patients. Twenty-five patients with 30 NF2-associated VSs with a mean follow-up of 121 months were identified. NF2-associated VSs exhibited excellent tumor control (10-year cumulative rate, 92% vs. 92% in sporadic VSs; p = 0.945) and worse overall survival (73% vs. 97%; p = 0.005), mainly due to tumor progression other than the treated VSs. The presence of NF2 was not associated with failed tumor control via multivariate Cox proportional hazard analyses. No difference in radiation-induced adverse events (RAEs) was confirmed between cohorts, and prescription dose (hazard ratio 8.30, 95% confidence interval 3.19–21.62, p < 0.001) was confirmed as a risk for cranial nerve injuries via multivariate analysis. Further analysis after propensity score matching using age, volume, and sex as covariates showed that NF2-associated VSs exhibited excellent local control (100% vs. 93%; p = 0.240) and worse overall survival (67% vs. 100%; p = 0.002) with no significant difference in RAEs. Excellent long-term tumor control and minimal invasiveness may make radiosurgery a favorable therapeutic option for NF2 patients with small to medium VS, preferably with non-functional hearing or deafness in combination with postoperative tumor growth or progressive non-operated tumors, or with functional hearing by patients’ wish.
Progressive Hypertension and Severe Left Ventricular Outflow Tract Obstruction
Cameron, Alan C. , Lang, Ninian N. , Chugh, Atul, Floras, John S. , Taler, Sandra J. , Delles, Christian , Lang, Ninian N , Dominiczak, Anna F. , Jennings, Garry , Batlle, Daniel , Bursztyn, Michael , Touyz, Rhian M. , Cameron, Alan C

Mayo Clinic

Hypertension | October 7, 2019 | Volume: 74 | Issue: 6 | Pages: 1216-1225

10.1161/hypertensionaha.119.13343 | PMID 31587571 Get It

Sudden cardiac arrest and ventricular arrhythmias following first type I myocardial infarction in the contemporary era
Amin, Mustapha, Kella, Danesh , Killu, Ammar M. , Padmanabhan, Deepak , Hodge, David O. , Golafshar, Michael A. , Chamberlain, Alanna M. , Lee, Justin Z. , Shen, Win‐Kuang , Friedman, Paul A. , Asirvatham, Samuel J. , Roger, Véronique L. , Mulpuru, Siva K. , Mulpuru, Siva K , Asirvatham, Samuel J , Kella, Danesh K , Chamberlain, Alanna M , Golafshar, Michael , Gersh, Bernard J.

Mayo Clinic

Journal of Cardiovascular Electrophysiology | October 7, 2019 | Volume: 30 | Issue: 12 | Pages: 2869-2876

10.1111/jce.14218 | PMID 31588605 Get It

AbstractIntroductionMyocardial infarction (MI) is associated with an increase in subsequent heart failure (HF), recurrent ischemic events, sudden cardiac arrest, and ventricular arrhythmias (SCA‐VA). The primary objective of the study to determine the role of intercurrent HF and ischemic events on the development of SCA‐VA following first type I MI.Methods and resultsA retrospective cohort study of patients experiencing first type 1 MI in Olmsted County, Minnesota (2002‐2012) was conducted by identifying patients using the medical records linkage system (Rochester epidemiology project). Patients aged ≥18 years were followed from the time of MI till death or 31 July, 2017. Intercurrent HF and ischemic events were the primary exposures following MI and their association with outcome SCA‐VA was assessed. Eight hundred and sixty‐seven patients (mean age was 63 ± 14.5 years; 69% male; 49.8% ST‐elevation myocardial infarction) who had their first type I MI during the study period were included. Majority of acute MI patients were revascularized using percutaneous coronary intervention and bypass surgery (628 [72.43%] and 87 [10.03%] respectively). During a mean follow‐up of 7.69 ± 4.17 years, HF, recurrent ischemic events and SCA‐VA occurred in 155 (17.9%), 245 (28.3%), and 40 (4.61%) patients respectively. Low ejection fraction (adjusted hazard ratio [HR] 0.95; 95% confidence interval [CI], 0.93‐0.98; P < .001), intercurrent HF (adjusted HR 3.11; 95% CI, 1.39‐6.95; P = .006) and recurrent ischemic events (adjusted HR 3.47; 95% CI, 1.68‐7.18; P < .001) were associated with subsequent SCA‐VA.ConclusionSCA‐VA occurred in a small proportion of patients after MI and is associated with intercurrent HF and recurrent ischemic events.
Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century
Yadav, Siddhartha , Karam, Dhauna , Riaz, Irbaz Bin , Xie, Hao , Durani, Urshila , Duma, Narjust , Mutter, Robert W. , Hawse, John R. , Jiménez, Rafael E. , Leon‐Ferre, Roberto A. , Ruddy, Kathryn J. , Florez, Narjust , Bin Riaz, Irbaz, Yadav, Siddhartha , Xie, Hao , Riaz, Irbaz B , Durani, Urshila , Giridhar, Karthik V. , Hieken, Tina J. , Boughey, Judy C. , Couch, Fergus J.

Mayo Clinic

Cancer | October 7, 2019 | Volume: 126 | Issue: 1 | Pages: 26-36

10.1002/cncr.32472 | PMID 31588557 Get It

Background Male breast cancer (MBC) is a rare disease for which there is limited understanding of treatment patterns and prognostic factors. Methods Men with TNM stage I to stage III breast cancer diagnosed between 2004 and 2014 in the National Cancer Data Base were included. Trends in treatment modalities were described using the average annual percentage change (AAPC) and estimated using Joinpoint software for the analysis of trends. Kaplan‐Meier curves and the multivariate Cox proportional hazards regression model were used to compare survival between subgroups and to identify prognostic factors. Results A total of 10,873 MBC cases were included, with a median age at diagnosis of 64 years. Breast‐conserving surgery was performed in 24% of patients, and 70% of patients undergoing breast conservation received radiotherapy. Approximately 44% of patients received chemotherapy, and 62% of patients with estrogen receptor–positive disease received endocrine therapy. Oncotype DX was ordered in 35% of patients with lymph node–negative, estrogen receptor–positive/human epidermal growth factor receptor 2 (HER2)‐negative tumors. During the study period, there was a significant increase in the rates of total mastectomy, contralateral prophylactic mastectomy, radiotherapy after breast conservation, ordering of Oncotype DX, and the use of endocrine therapy ( P < .05). On multivariate analysis, factors found to be associated with worse overall survival were older age, black race, higher Charlson Comorbidity Index, high tumor grade and stage of disease, and undergoing total mastectomy. Residing in a higher income area; having progesterone receptor–positive tumors; and receipt of chemotherapy, radiotherapy, and endocrine therapy were associated with better overall survival. Conclusions Despite the lack of prospective randomized trials in patients with MBC, the results of the current study demonstrated that the treatment of this disease has evolved over the years. These findings further the understanding of the modern treatment and prognosis of MBC, and identify several areas for further research.
Normative and isolated rapid eye movement sleep without atonia in adults without REM sleep behavior disorder
Feemster, John, Jung, Youngsin, Timm, Paul, Westerland, Sarah M., Gossard, Thomas , Teigen, Luke, Buchal, Lauren A, Cattaneo, Elena F. D. , Imlach, C., McCarter, Stuart J. , Smith, Kevin L. , Silber, Michael H. , Louis, Erik K. St. , Feemster, John C, Timm, Paul C, Gossard, Thomas R, Teigen, Luke N, Imlach, Charlotte A, St Louis, E K , Gossard, Thomas R , Smith, Kevin L, Boeve, Bradley F. , McCarter, Stuart J

Mayo Clinic

Sleep | October 6, 2019 | Volume: 42 | Issue: 10 | Pages: No page available

10.1093/sleep/zsz124 | PMID 31587043 Get It

Abstract Study Objectives Values for normative REM sleep without atonia (RSWA) remain unclear. Older age and male sex are associated with greater RSWA, and isolated elevated RSWA has been reported. We aimed to describe normative RSWA and characterize isolated RSWA frequency in adults without REM sleep behavior disorder (RBD). Methods We visually quantified phasic, “any,” and tonic RSWA in the submentalis (SM) and anterior tibialis (AT) muscles, and the automated Ferri REM Atonia Index during polysomnography in adults without RBD aged 21–88. We calculated RSWA percentiles across age and sex deciles and compared RSWA in older (≥ 65) versus younger (<65) men and women. Isolated RSWA (exceeding diagnostic RBD cutoffs, or >95th percentile) frequency was also determined. Results Overall, 95th percentile RSWA percentages were SM phasic, any, tonic = 8.6%, 9.1%, 0.99%; AT phasic and “any” = 17.0%; combined SM/AT phasic, “any” = 22.3%, 25.5%; and RAI = 0.85. Most phasic RSWA burst durations were ≤1.0 s (85th percentiles: SM = 1.07, AT = 0.86 seconds). Older men had significantly higher AT RSWA than older women and younger patients (all p < 0.04). Twenty-nine (25%, 18 men) had RSWA exceeding the cohort 95th percentile, while 17 (14%, 12 men) fulfilled diagnostic cutoffs for phasic or automated RBD RSWA thresholds. Conclusions RSWA levels are highest in older men, mirroring the demographic characteristics of RBD, suggesting that older men frequently have altered REM sleep atonia control. These data establish normative adult RSWA values and thresholds for determination of isolated RSWA elevation, potentially aiding RBD diagnosis and discussions concerning incidental RSWA in clinical sleep medicine practice.
re: Comparison of Technical Failure of MR Elastography for Measuring Liver Stiffness Between Gradient‐Recalled Echo and Spin‐Echo Echo‐Planar Imaging: A Systematic Review and Meta‐Analysis
Ehman, Richard L. , Ehman, Richard

Mayo Clinic

Journal of Magnetic Resonance Imaging | October 6, 2019 | Volume: 51 | Issue: 4 | Pages: 1103-1104

10.1002/jmri.26937 | PMID 31587415 Get It

Determining the conversion ratios for oral versus sublingual administration of tacrolimus in solid organ transplant recipients
Sagheer, Tiba Al, Enderby, Cher Y. , Al Sagheer, Tiba

Mayo Clinic

Clinical Transplantation | October 6, 2019 | Volume: 33 | Issue: 10 | Pages: No page available

10.1111/ctr.13727 | PMID 31587353 Get It

AbstractTacrolimus is utilized as maintenance immunosuppression in solid organ transplant (SOT). Current literature has reported conflicting conversion ratios when transitioning between oral and sublingual tacrolimus, and the exact conversion ratio has not been fully established in SOT. The purpose of this study was to determine the conversion ratios between oral and sublingual tacrolimus needed to achieve equivalent whole blood concentrations in heart, kidney, liver, and lung transplant recipients. A retrospective, single‐center analysis was conducted at Mayo Clinic in Florida. One hundred and eighteen hospitalized SOT recipients who received oral and sublingual tacrolimus during the same inpatient admission from June 1, 2012, through June 1, 2017, were reviewed. The median conversion ratio of sublingual to oral tacrolimus was 1.34 (IQR: 1.03‐1.93) in all SOT, 1.25 (IQR: 1.08‐1.64) in heart transplant, 1.23 (IQR: 1.1‐2.06) in kidney transplant, 1.64 (IQR: 1.27‐2.29) in liver transplant, and 1.34 (IQR: 0.94‐1.93) in lung transplant. A slightly higher dose of oral tacrolimus is needed in the majority of solid organ recipients in our population when converting between sublingual to oral tacrolimus administration.
Polyneuritis cranialis after acute tularemia infection: A case study
Blech, Benzion , Asbury, Kara , Orenstein, Robert , Ross, Mark A., Grill, Marie , Christiansen, Michael

Mayo Clinic

Muscle & Nerve | October 6, 2019 | Volume: 61 | Issue: 1 | Pages: No page available

10.1002/mus.26725 | PMID 31587301 Get It